This study describes, for the first time, the production and use of an "internal-image" anti-idiotypic monoclonal antibody (MAb) to elicit a rotavirus-specific antibody response. An immunoglobulin G2a MAb, designated RQ31 (MAbl), specific for the outer capsid protein VP4 of bovine Q17 rotavirus and capable of neutralizing viral infection in vitro was used to generate an anti-idiotypic MAb (MAb2). This MAb2, designated RQA2, was selected by enzyme-linked immunosorbent assay (ELISA) using F(ab')2 fragments of RQ31. RQA2 (MAb2) inhibited the binding of RQ31 (MAbl) to the virus but had no effect on the binding of other rotavirus-specific MAbs. The MAb2 also inhibited virus neutralization mediated by MAbl in a dose-dependent fashion. Naive guinea pigs immunized with the MAb2 produced anti-anti-idiotypic antibodies (Ab3) that reacted with bovine Q17 rotavirus in an ELISA and neutralized rotavirus infection in vitro. The Ab3 response was characterized as MAbl-like because the Ab3 recognizes only the Q17 and neonatal calf diarrhea virus rotavirus strains in ELISA, as did RQ31 (MAbl). The Ab3 response also possessed two other characteristics of RQ31: the abilities to bind the 1.36 (double-capsid) but not the 1.38 (single-capsid) purified rotavirus fraction in ELISA and to immunoprecipitate the VP4 rotavirus protein.
Rotaviruses have been implicated as a cause of diarrhea in children and newborn animals (17) . In many countries, rotaviruses are considered the major infectious cause of diarrhea in calves (4, 15, 26, 32, 38) . Various approaches to protecting calves against rotavirus-associated diarrhea have been tried. Limited success has been achieved by passive immunization mediated by specific neutralizing antibodies in colostrum and milk (35) . This type of immune response appears to occur in vivo, since most cattle are seropositive for rotavirus and have high colostral antibody titers that rapidly decrease to low, nonprotective levels in the milk (1) . Intramuscular vaccination with rotavirus and adjuvant has been used to enhance antibody titers in serum, colostrum, and milk (3, 9, 27, (34) (35) (36) 42) . In most of these studies, colostral antibodies prevented or reduced the severity of diarrhea. However, in only one study was complete protection observed (34) . In this particular case, calves were fed with pooled colostrum from cows vaccinated with a liverotavirus preparation suspended in incomplete Freund's adjuvant (IFA). Oral immunization of calves is potentially an important approach to rotavirus vaccination, since it would eliminate the need for continuous feeding with colostrum or milk containing high concentrations of specific antibody. Unfortunately, good protection by using this method has not been reported (2, 8, 15) .
Neutralizing-antibody production and consequent protection against viral infection are mediated by epitopes on the outer capsid proteins VP4 and VP7 (17) . In recent years, new vaccination alternatives for rotavirus, such as the use of synthetic peptides corresponding to conserved regions on VP7 and VP4, have been proposed (22) . Similarly, Brussow * Corresponding author. et al. (6) reported the enhancement of rotavirus-specific antibodies in the milk of cows vaccinated with a subunit vaccine composed of an empty rotavirus capsid and VP7. Brussow et al. (7) also proposed the use of the monkey rotavirus SAil to immunize cows because of the heterotypic response to monotype vaccines (7, 37) .
Idiotypic vaccines are another promising alternative to conventional vaccines. Anti-idiotypic antibodies (Ab2) have been classified into four groups (alpha, beta, gamma, and delta) according to their specificities for different regions of the target antibody (Abl) (21) . Only types beta and gamma bind to the antigen-binding site (paratope) of the Abl. The beta type mimics an antigenic determinant and binds to the Abl in a fashion similar to its binding to the epitope of the original antigen. The gamma type binds to a paratopeassociated idiotope but bears no structural resemblance to the antigen (21) . Ab2, which mimic the antigens, have been tested as immunogens for several viruses, and several of these "internal-image" Ab2 (beta type) have elicited virusspecific humoral and/or cell-mediated immune responses which confer protective immunity against viral infections (5, 16, 18-21, 24, 25, 29, 30, 33, 39, 41 (Fig. 1) in F(ab')2 ELISA, and only RQ31 was able to inhibit the MAb2-MAbl reaction in a dose-dependent fashion (Fig. 2) (Fig. 3) . When a control MAb IgGl or IgG2a was used as a competitor, inhibition of more than 10% was never observed. RQA2 binds to MAbl close to the antigen-binding site of the MAbl, since RQA2 was able to inhibit the virus infection-neutralizing activity of the MAbl, as shown in Fig. 4 . This inhibition was not the result of nonspecific MAb2 reactions, since the IgGl H17 control MAb had no effect.
Rabbit and bovine antisera raised against Q17 purified rotavirus did not bind to the MAb2 in ELISA or IF tests.
An investigation of the Ab3 response to RQA2 was carried out in order to determine whether the MAb2 was either a gamma or a beta Ab2. Mice Tables 1 and  2 show that both species produced rotavirus-specific antibodies in a dose-dependent fashion in response to MAb2 immunization. In addition, Quil A and Freund's adjuvant were equally effective in the production of this Ab3 response. However, the FF neutralization test showed that only guinea pig Ab3 could neutralize rotavirus infectivity. Preimmune sera and sera from mice immunized with KLHadjuvant or from guinea pigs immunized with the control IgGl H17 MAb did not bind to or neutralize rotavirus. As expected, the mouse or guinea pig Ab3 were also able to inhibit the MAbl-MAb2 reaction, as demonstrated by a competitive ELISA (Fig. 5) . These results suggest that RQA2 is a beta-type Ab2.
In order to further characterize the Ab3 as Abl-like, their binding patterns against different rotavirus strains and dif- ferent preparations of purified rotavirus were investigated. The guinea pig Ab3 bound to only Q17 and NCDV rotavirus strains in ELISA, as did RQ31 (Table 3) . Like RQ31, guinea pig Ab3 recognized the purified viral band (1.36; double capsid, which contains VP4) but not the 1.38 band (single capsid, which did not contain VP4) (Table 3) . Immunoprecipitation of the 35S-labeled rotavirus proteins by the Ab3 showed that VP4 was the only immunoprecipitated protein (Fig. 6 ). These results indicate that the Ab3 response is very similar to the MAbl response. DISCUSSION RQ31 (MAbl) binds to the neutralizing epitope on VP4 of bovine rotavirus and is conformation specific. This antibody was used to produce MAb2, which specifically inhibited the binding of MAbl to the virus in ELISA and neutralization tests. These results show that the MAb2 binds to MAbl close to the antigen-binding site of MAbl. This suggests that MAb2 is either a gamma-or beta-type Ab2 (21) . However, the rotavirus-specific polyclonal rabbit and bovine antisera These results imply that the RQA2 is a gamma-type MAb2 or that the MAbl-specific VP4 neutralizing epitope was not present (or not immunogenic) in the rabbit and bovine immunization protocols. This could have occurred because the antigen preparation used in the immunization of these species was different from that used in the immunization of the mice for MAbl production. In the first case, the antigen used was rotavirus purified on a cesium chloride gradient, whereas rotavirus used for immunization of mice was partially purified on a sucrose cushion. The expression of epitopes on VP4 could be very complicated because of the protease sensitivity of the epitopes and their disposition as complex spikes in the outer capsid. It has previously been demonstrated that the interaction between VP4 and VP7 affects the expression of a neutralizing epitope on VP4 (10). The MAb2 was able to inhibit 30% of the binding to rotavirus of RQ104, a nonneutralizing anti-VP4 IgG2a MAb. This inhibition could be due to some degree of cross-reactivity 10 ±1l of rotavirus-specific rabbit polyclonal antibodies (Q17), 100 ,ul of supernatant from NS-1 culture cells (NS-ls), 100 pul of rotavirus-specific MAbl (RQ31), 10 ,ul of serum from guinea pig immunized with 100 pLg of RQA2 associated with Quil A at day 0 (Ab3-0), or 10 ,ul of serum from guinea pig immunized with 100 pLg of RQA2 associated with Quil A at day 75 (Ab3).
between the RQ31 and RQ104 epitopes. The epitope mapping of VP4 will allow us to clarify this possibility.
The MAb2 was used to inoculate mice and guinea pigs in order to study the Ab3 response and to characterize the Ab2 as either gamma or beta type. RQA2 was able to elicit a rotavirus-specific Ab3 response in both animals, as demonstrated by ELISA. Only the Ab3 serum from guinea pig neutralized virus infectivity. Since both mice and guinea pigs developed an antirotavirus humoral response, as detected by ELISA, we expected neutralization activity in both samples. The inability of mouse Ab3 to neutralize rotavirus is difficult to explain. The regimen of immunization used to elicit a syngeneic immune response was probably inadequate, since the specific rotavirus antibody levels detected by ELISA remained very low during the course of the experiment. This might explain why we failed to detect any neutralizing activity in the Ab3 mouse sera. However, we were able to detect an Ab3 neutralizing rotavirus-specific response in guinea pig, a heterogeneic species. This suggests that the MAb2 described in the present study is a beta-type Ab2 (21, 25 ). This conclusion is further supported by the fact that guinea pig Ab3 were characterized as MAbl-like by the ELISA reactivity patterns against different rotavirus strains and different preparations of rotavirus as well as by an immunoprecipitation test. Reactivity against various rotavirus proteins would be expected in the case of a nonspecific Ab3 response or if the MAb2 was a regulatory Ab2. Since no reactivity against rotavirus proteins other than VP4 was observed in the sensitive immunoprecipitation assay, these results lead to the conclusion that the beta-type MAb2 described in this study represents a neutralizing epitope on VP4.
The induction of rotavirus-neutralizing antibodies by internal-image-type RQA2, which can be produced in unlimited amounts, makes this MAb2 interesting as a potential immunogen against rotavirus. This antibody could be used for vaccination of cows to develop a transferable passive immunity or for oral vaccination of calves to develop an active local immunity (23, 40) . The utilization of Ab2 vaccine for inducing protective mucosal immunity has been demonstrated in a Streptococcus mutans system (23 
